Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an update.
MIRA Pharmaceuticals, Inc. announces a significant leadership change as Michael Jerman resigns from the board to pursue other interests, and Matthew Pratt Whalen steps in as the new board member and Chairman of the Audit Committee. Whalen, a seasoned CPA with vast experience in public accounting and corporate finance, is expected to bring substantial expertise and strategic oversight to the company, enhancing its financial governance and growth potential.
Find detailed analytics on MIRA stock on TipRanks’ Stock Analysis page.
